US$ 20.92
novo nordisk is cutting prices on its popular glp-1 drugs. cuts of Ozempic, Wegovy, and Rybelsus by up to 50% Novo Nordisk to cut 9,000
Description
PMCID: PMC12808432

This GLP-R1 agonist seems to increase oncogenesis in multiple tissues, including the thyroid, bladder, pancreatic, and colorectal [97, 110, 121]

Like LIR, the race of patients involved in related clinical studies is relatively small
Danish pharmaceutical company Novo Nordisk started making Ozempic to help people with diabetes

Its priced at a discount of about 14% to branded Victoza, according to pricing data shared by Erin Fox, a drug shortages and pricing expert at the University of Utah Health
